SciBac has a total of 17 patents globally, out of which 2 have been granted. Of these 17 patents, more than 64% patents are active. United States of America is where SciBac has filed the maximum number of patents, followed by Australia and India. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of SciBac.
SciBac was founded in the year 2015. The Company is a developer of biotherapeutics intended to treat antibiotic diseases. The company’s technology improves beneficial microorganisms using a patented merge platform that uses a type of directed evolution to increase therapeutic efficac.
Do read about some of the most popular patents of SciBac which have been covered by us in this article and also you can find SciBac patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over SciBac patent portfolio.
How many patents does the founder and the CEO of SciBac have?
The founders Anthony Cann has 0 patent, Derik Twomey has 0 patent and CEO Jeanette Mucha has 0 patent.
How many patents does SciBac have?
SciBac has a total of 17 patents globally. These patents belong to 4 unique patent families. Out of 17 patents, 11 patents are active.
How Many Patents did SciBac File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | SciBac Applications Filed | SciBac Patents Granted |
| 2021 | 3 | 1 |
| 2019 | 5 | – |
| 2018 | 2 | – |
| 2017 | 1 | 1 |
| 2016 | 6 | – |
How many SciBac patents are Alive/Dead?
How Many Patents did SciBac File in Different Countries?
Countries in which SciBac Filed Patents
| Country | Patents |
| United States Of America | 4 |
| Australia | 2 |
| India | 2 |
| Canada | 2 |
| China | 2 |
| Europe | 2 |
| Japan | 1 |
Where are Research Centres of SciBac Patents Located?
The Research Centre for all the SciBac patents is the United States of America.
Best SciBac Patents
CN113226342A is the most popular patent in the SciBac portfolio. It has received 1 citation so far from company like Zhejiang University.
Below is the list of most cited patents of SciBac:
| Publication Number | Citation Count |
| CN113226342A | 1 |
| WO2017087429A1 | 1 |
What Percentage of SciBac US Patent Applications were Granted?
SciBac (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 50.0%.
Below are the key stats of SciBac patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for SciBac?
| Law Firm | Total Applications | Success Rate |
| Fisherbroyles Llp Main Cn | 1 | 0.00% |
| Jill Jacobson | 1 | 100.00% |
List of SciBac Patents
| SciBac Patents | Title |
| EP3866820A4 | Live Biotherapeutics To Treat And Prevent Lung Conditions |
| EP3377901A4 | A Method For Producing Chimeric Microbial Hybrids |
| CN108351354B | Method For Producing A Hybrid Of A Chimeric Microorganism |
| CN113226342A | Live Biological Therapeutic Agent For Treating And Preventing Lung Condition |
| CA3116559A1 | Live Biotherapeutics To Treat And Prevent Lung Conditions |
| CA3002823A1 | A Method For Producing Chimeric Microbial Hybrids |
| AU2019361036A1 | Live Biotherapeutics To Treat And Prevent Lung Conditions |
| AU2016355409A1 | A Method For Producing Chimeric Microbial Hybrids |
| IN202117022000A | Live Biotherapeutics To Treat And Prevent Lung Conditions |
| IN201817021227A | A Method For Producing Chimeric Microbial Hybrids |
| JP2022064330A | Method To Manufacture A Chimeric Microbial Hybrid |
| US9765358B2 | Method For Producing Chimeric Microbial Hybrids |
| US20210353693A1 | Live Biotherapeutics To Treat And Prevent Lung Conditions |
| US20190367946A1 | Method For Producing Chimeric Microbial Hybrids |
| US20180087071A1 | Method For Producing Chimeric Microbial Hybrids |
| WO2020081742A3 | Live Biotherapeutics To Treat And Prevent Lung Conditions |
| WO2017087429A1 | A Method For Producing Chimeric Microbial Hybrids |
What are SciBac key innovation segments?
What Technologies are Covered by SciBac?
The chart below distributes patents filed by SciBac